OraQuick Ebola Antigen Test
Device
OraSure Technologies Inc.
Total Payments
$344,147
Transactions
6
Doctors
4
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $344,147 | 6 | 4 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $344,147 | 6 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Specificity of OraQuick Ebola Antigen Test | OraSure Technologies Inc. | $264,687 | 4 |
| Reproducibility and performance studies | OraSure Technologies Inc. | $42,450 | 0 |
| Reproducibility of the OraQuick Ebola Antigen Test | OraSure Technologies Inc. | $37,010 | 0 |
Top Doctors Receiving Payments for OraQuick Ebola Antigen Test
Ad
Manufacturing Companies
- OraSure Technologies Inc. $344,147
Product Information
- Type Device
- Total Payments $344,147
- Total Doctors 4
- Transactions 6
About OraQuick Ebola Antigen Test
OraQuick Ebola Antigen Test is a device associated with $344,147 in payments to 4 healthcare providers, recorded across 6 transactions in the CMS Open Payments database. The primary manufacturer is OraSure Technologies Inc..
Payment data is available from 2018 to 2018. In 2018, $344,147 was paid across 6 transactions to 4 doctors.
The most common payment nature for OraQuick Ebola Antigen Test is "Unspecified" ($344,147, 100.0% of total).
OraQuick Ebola Antigen Test is associated with 3 research studies, including "Specificity of OraQuick Ebola Antigen Test" ($264,687).